Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus - PubMed (original) (raw)
. 2012 Dec;32(12):3050-7.
doi: 10.1161/ATVBAHA.112.255190. Epub 2012 Oct 18.
Affiliations
- PMID: 23087360
- DOI: 10.1161/ATVBAHA.112.255190
Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus
Bruno Vergès et al. Arterioscler Thromb Vasc Biol. 2012 Dec.
Abstract
Objective: Retinol-binding protein 4 (rbp4) is an adipokine secreted by adipocytes and liver, whose levels are elevated in type 2 diabetes mellitus (T2DM). Plasma levels of rbp4 and triglycerides are strongly correlated in T2DM. However, we do not know whether this association is direct or indirect via liver fat content, and the link between rbp4 and triglyceride metabolism remains unknown.
Methods and results: Liver fat measurement by proton spectroscopy was performed in 221 patients with T2DM, and an in vivo kinetic study with stable isotopes was carried out in 14 patients with T2DM. In multivariate analysis, triglycerides were associated positively with rbp4 (β=0.273, P<0.0001), apolipoprotein (apo) B (β=0.258, P<0.0001), and liver fat (β=0.191, P=0.002) and negatively with high-density lipoprotein cholesterol (β=-0.442, P<0.0001). rbp4 was correlated positively with apoB100 very-low-density lipoprotein (VLDL) pool (r=0.62, P=0.017) and negatively with VLDL-apoB100 total fractional catabolic rate (r=-0.66, P=0.001). In multivariate analysis, rbp4 (P=0.015), plasma triglycerides (P=0.024), and sex (P=0.026) were independently associated with VLDL-apoB100 total fractional catabolic rate.
Conclusions: In T2DM, plasma rbp4 level is associated with plasma triglycerides, independently of liver fat content. There is a strong independent negative correlation between plasma rbp4 and VLDL-apoB100 total fractional catabolic rate. These data suggest that rbp4 may be involved in the pathophysiology of hypertriglyceridemia in T2DM by reducing VLDL catabolism.
Similar articles
- Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M. Ouguerram K, et al. J Pharmacol Exp Ther. 2003 Jul;306(1):332-7. doi: 10.1124/jpet.103.048991. Epub 2003 Apr 8. J Pharmacol Exp Ther. 2003. PMID: 12684543 - Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B, Anderson RA, Kuzuya T, Kitaura Y, Shimomura Y. Qin B, et al. Atherosclerosis. 2012 Jun;222(2):409-16. doi: 10.1016/j.atherosclerosis.2012.03.033. Epub 2012 Apr 11. Atherosclerosis. 2012. PMID: 22546076 - High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Häring HU. Stefan N, et al. Diabetes Care. 2007 May;30(5):1173-8. doi: 10.2337/dc06-2342. Epub 2007 Jan 26. Diabetes Care. 2007. PMID: 17259477 - Regulation of plasma triglycerides in insulin resistance and diabetes.
Ginsberg HN, Zhang YL, Hernandez-Ono A. Ginsberg HN, et al. Arch Med Res. 2005 May-Jun;36(3):232-40. doi: 10.1016/j.arcmed.2005.01.005. Arch Med Res. 2005. PMID: 15925013 Review. - The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways.
Fisher EA. Fisher EA. Biochim Biophys Acta. 2012 May;1821(5):778-81. doi: 10.1016/j.bbalip.2012.02.001. Epub 2012 Feb 10. Biochim Biophys Acta. 2012. PMID: 22342675 Free PMC article. Review.
Cited by
- Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older.
Majerczyk M, Kocełak P, Choręza P, Arabzada H, Owczarek AJ, Bożentowicz-Wikarek M, Brzozowska A, Szybalska A, Puzianowska-Kuźnicka M, Grodzicki T, Więcek A, Olszanecka-Glinianowicz M, Chudek J. Majerczyk M, et al. J Endocrinol Invest. 2018 Oct;41(10):1211-1219. doi: 10.1007/s40618-018-0856-6. Epub 2018 Mar 9. J Endocrinol Invest. 2018. PMID: 29524177 Free PMC article. - Adipokine Retinol Binding Protein 4 and Cardiovascular Diseases.
Ji Y, Song J, Su T, Gu X. Ji Y, et al. Front Physiol. 2022 Mar 2;13:856298. doi: 10.3389/fphys.2022.856298. eCollection 2022. Front Physiol. 2022. PMID: 35309061 Free PMC article. Review. - Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients.
Rocha M, Bañuls C, Bellod L, Rovira-Llopis S, Morillas C, Solá E, Víctor VM, Hernández-Mijares A. Rocha M, et al. PLoS One. 2013 Nov 4;8(11):e78670. doi: 10.1371/journal.pone.0078670. eCollection 2013. PLoS One. 2013. PMID: 24223837 Free PMC article. - Expression of retinol binding protein 4 and nuclear factor-κB in diabetic rats with atherosclerosis and the intervention effect of pioglitazone.
Zhou W, Ye S, Li J. Zhou W, et al. Exp Ther Med. 2016 Aug;12(2):1000-1006. doi: 10.3892/etm.2016.3340. Epub 2016 May 16. Exp Ther Med. 2016. PMID: 27446311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous